Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.

Virus genes - 1 Dec 2021

Müller Katharina, Girl Philipp, Giebl Andreas, Gruetzner Stefanie, Antwerpen Markus, Khatamzas Elham, Wölfel Roman, von Buttlar Heiner

Abstract excerpt

SARS-CoV-2 infections elicit a humoral immune response capable of neutralising the virus. However, multiple variants have emerged with mutations in the spike protein amongst others, the key target of neutralising antibodies. We evaluated the neutralising efficacy of 89 serum samples from patients, infected with SARS-CoV-2 in the beginning of 2020, against two virus variants isolated from acutely infected patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to COVID-19

Share to Mutation

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 34608598
DOI: 10.1007/s11262-021-01871-8
PMCID: PMC8489549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.PMID 34608598Read ↗

SARS-CoV-2 spike E484K mutation reduces antibody neutralisationSemantic proximity Read ↗

Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines.Semantic proximity Read ↗

SARS-CoV-2 variants, spike mutations and immune escape.Semantic proximity Read ↗

Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2Semantic proximity Read ↗

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variantSemantic proximity Read ↗

The impact of Spike mutations on SARS-CoV-2 neutralizationSemantic proximity Read ↗

Structural and functional dissection of neutralisation differences among SARS-CoV-2 variants using antigenicity prediction and CR3022 binding analysis.Semantic proximity Read ↗

Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions.Semantic proximity Read ↗

Sensitivity of BA.2.86 to prevailing neutralising antibody responsesSemantic proximity Read ↗

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.Semantic proximity Read ↗

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Semantic proximity Read ↗

The rise and fall of an emerging SARS-CoV-2 variant with the spike protein mutation L452RSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.